| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |